Premium
OUTCOMES FOR PATIENTS WITH MANTLE CELL LYMPHOMA EXPERIENCING FRONTLINE TREATMENT FAILURE: A MULTICENTER RETROSPECTIVE STUDY
Author(s) -
Bond D.A.,
Switchenko J.,
Maddocks K.,
Churnetski M.,
Goyal S.,
Shanmugasundaram K.,
Calzada O.,
Kolla B.,
Bachanova V.,
Gerson J.,
Barta S.,
Hill B.,
Salwaha Y.,
Martin P.,
Maldonado E.,
Gordon M.,
Danilov A.,
Grover N.,
Mathews S.,
Burkart M.,
Karmali R.,
Ghosh N.,
Park S.,
Epperla N.,
Badar T.,
Guo J.,
Hamadani M.,
Fenske T.,
Malecek M.,
Kahl B.,
Flowers C.,
Blum K.,
Cohen J.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.77_2631
Subject(s) - medicine , mantle cell lymphoma , progression free survival , oncology , population , cytarabine , overall survival , lymphoma , chemotherapy , environmental health